Sweet and Sticky. Diabetic Platelets, Enhanced Reactivity, and Cardiovascular Risk**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

Journal of the American College of Cardiology

Volumn 50, Issue 16, 2007, Pages 1548-1550

  Simon, Daniel I ^a   Schmaier, Alvin H ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ADRENALIN; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; CYTOCHROME P450 3A4; TICLOPIDINE; WARFARIN;

ANGINA PECTORIS; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DRUG RESPONSE; EDITORIAL; FLOW CYTOMETRY; HEART INFARCTION; HIGH PLATELET REACTIVITY; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

ANGINA, UNSTABLE; ASPIRIN; BLOOD PLATELETS; CORONARY ARTERY DISEASE; DEATH, SUDDEN, CARDIAC; DIABETES MELLITUS, TYPE 2; HUMANS; MYOCARDIAL INFARCTION; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PROGNOSIS; STROKE; TICLOPIDINE;

EID: 34948907941     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.07.023     Document Type: Editorial

References (30)

1. Juul-Moller S., Edvardsson N., Jahnmatz B., Rosen A., Sorensen S., and Omblus R. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group. Lancet 340 (1992) 1421-1425
2. Herbert J., Dol F., Bernat A., Falotico R., Lale A., and Savi P. The antiaggregating and antithrombotic activity of clopidogrel is potentiated by aspirin in several experimental models in the rabbit. Thromb Haemost 80 (1998) 512-518
3. Schomig A., Neumann F.J., Kastrati A., et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 334 (1996) 1084-1089
4. Leon M., Baim D., Popma J., et al. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. N Engl J Med 339 (1998) 1665-1671
5. Yusuf S., Zhao F., Mehta S.R., Chrolavicius S., Tognoni G., and Fox K.K. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345 (2001) 494-502
6. Bhatt D.L. Aspirin resistance: more than just a laboratory curiosity. J Am Coll Cardiol 43 (2004) 1127-1129
7. Lau W.C., Gurbel P.A., Watkins P.B., et al. Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance. Circulation 109 (2004) 166-171
8. Cheng X., Chen W.H., and Simon D.I. Aspirin resistance or variable response or both?. Am J Cardiol 98 (2006) 11N-17N
9. Lev E.I., Patel R.T., Maresh K.J., et al. Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance. J Am Coll Cardiol 47 (2006) 27-33
10. Matetzky S., Shenkman B., Guetta V., et al. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation 109 (2004) 3171-3175
11. Barragan P., Bouvier J., Roquebert P., et al. Resistance to thienopyridines: clinical detection of coronary stent thrombosis by monitoring of vasodilator-stimulated phosphoprotein phosphorylation. Catheter Cardiovasc Interv 59 (2003) 295-302
12. Angiolillo D.J., Bernardo E., Sabaté M., et al. Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease. J Am Coll Cardiol 50 (2007) 1541-1547
13. Alessandrini P., McRae J., Feman S., and FitzGerald G.A. Thromboxane biosynthesis and platelet function in type I diabetes mellitus. N Engl J Med 319 (1988) 208-212
14. Sibbing D., von Beckerath O., Schomig A., Kastrati A., and von Beckerath N. Diabetes mellitus and platelet function after administration of aspirin and a single 600 mg dose of clopidogrel. J Thromb Haemost 4 (2006) 2566-2568
15. Cuisset T., Frere C., Quilici J., et al. Benefit of a 600-mg loading dose of clopidogrel on platelet reactivity and clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing coronary stenting. J Am Coll Cardiol 48 (2006) 1339-1345
16. Yee D.L., Sun C.W., Bergeron A.L., Dong J.F., and Bray P.F. Aggregometry detects platelet hyperreactivity in healthy individuals. Blood 106 (2005) 2723-2729
17. Zhou L., and Schmaier A.H. Platelet aggregation testing in platelet-rich plasma: description of procedures with the aim to develop standards in the field. Am J Clin Pathol 123 (2005) 172-183
18. Gurbel P.A., Bliden K.P., Hayes K.M., Yoho J.A., Herzog W.R., and Tantry U.S. The relation of dosing to clopidogrel responsiveness and the incidence of high post-treatment platelet aggregation in patients undergoing coronary stenting. J Am Coll Cardiol 45 (2005) 1392-1396
19. Clinical and Laboratory Standards Institute (CLSI). Platelet Function Testing by Aggregometry; Proposed Guideline. CLSI document H58-P (ISBN 1-56238-000-0).
20. Beckman J.A., Creager M.A., and Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 287 (2002) 2570-2581
21. Watala C. Blood platelet reactivity and its pharmacological modulation in (people with) diabetes mellitus. Curr Pharm Des 11 (2005) 2331-2365
22. Assert R., Scherk G., Bumbure A., Pirags V., Schatz H., and Pfeiffer A.F. Regulation of protein kinase C by short term hyperglycaemia in human platelets in vivo and in vitro. Diabetologia 44 (2001) 188-195
23. Michno A., Bielarczyk H., Pawelczyk T., Jankowska-Kulawy A., Klimaszewska J., and Szutowicz A. Alterations of adenine nucleotide metabolism and function of blood platelets in patients with diabetes. Diabetes 56 (2007) 462-467
24. Calverley D.C., Hacker M.R., Loda K.A., et al. Increased platelet Fc receptor expression as a potential contributing cause of platelet hypersensitivity to collagen in diabetes mellitus. Br J Haematol 121 (2003) 139-142
25. Lee H., Nurden A.T., Thomaidis A., and Caen J.P. Relationship between fibrinogen binding and the platelet glycoprotein deficiencies in Glanzmann's thrombasthenia type I and type II. Br J Haematol 48 (1981) 47-57
26. Zou M., Yesilkaya A., and Ullrich V. Peroxynitrite inactivates prostacyclin synthase by heme-thiolate-catalyzed tyrosine nitration. Drug Metab Rev 31 (1999) 343-349
27. Konstantinides S., Schafer K., Koschnick S., and Loskutoff D.J. Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity. J Clin Invest 108 (2001) 1533-1540
28. Bodary P.F., Westrick R.J., Wickenheiser K.J., Shen Y., and Eitzman D.T. Effect of leptin on arterial thrombosis following vascular injury in mice. JAMA 287 (2002) 1706-1709
29. Takahashi S., Ushida M., Komine R., et al. Increased basal platelet activity, plasma adiponectin levels, and diabetes mellitus are associated with poor platelet responsiveness to in vitro effect of aspirin. Thromb Res 119 (2007) 517-524
30. Angiolillo D.J., Shoemaker S.B., Desai B., et al. Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease: results of the Optimizing Antiplatelet Therapy in Diabetes Mellitus (OPTIMUS) study. Circulation 115 (2007) 708-716